A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

NCT00398216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

903

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis
Hip Replacement

Interventions

DRUG: DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

Sponsor

Daiichi Sankyo